Tai‐Jan Chiu

1.7k total citations
56 papers, 431 citations indexed

About

Tai‐Jan Chiu is a scholar working on Oncology, Surgery and Otorhinolaryngology. According to data from OpenAlex, Tai‐Jan Chiu has authored 56 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 20 papers in Surgery and 17 papers in Otorhinolaryngology. Recurrent topics in Tai‐Jan Chiu's work include Head and Neck Cancer Studies (17 papers), Pancreatic and Hepatic Oncology Research (10 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers). Tai‐Jan Chiu is often cited by papers focused on Head and Neck Cancer Studies (17 papers), Pancreatic and Hepatic Oncology Research (10 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers). Tai‐Jan Chiu collaborates with scholars based in Taiwan and United States. Tai‐Jan Chiu's co-authors include Shau-Hsuan Li, Chih‐Yen Chien, Sheng‐Dean Luo, Chang‐Han Chen, Hsin‐Ting Tsai, Fu‐Min Fang, Chien-Ting Liu, Yen‐Yang Chen, Kun‐Ming Rau and Wei‐Chih Chen and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Tai‐Jan Chiu

52 papers receiving 427 citations

Peers

Countries citing papers authored by Tai‐Jan Chiu

Since Specialization

Citations

This map shows the geographic impact of Tai‐Jan Chiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tai‐Jan Chiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tai‐Jan Chiu more than expected).

Fields of papers citing papers by Tai‐Jan Chiu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tai‐Jan Chiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tai‐Jan Chiu. The network helps show where Tai‐Jan Chiu may publish in the future.

Co-authorship network of co-authors of Tai‐Jan Chiu

This figure shows the co-authorship network connecting the top 25 collaborators of Tai‐Jan Chiu. A scholar is included among the top collaborators of Tai‐Jan Chiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tai‐Jan Chiu. Tai‐Jan Chiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The risk of free flap revision and subsequent medical costs in patients with hypopharyngeal cancer 2024 ·European Archives of Oto-Rhino-Laryngology ·(unknown), Sheng‐Dean Luo, Wei‐Chih Chen, Tai‐Jan Chiu, Yuming Wang, Shao‐Chun Wu, Yao‐Hsu Yang, Shau-Hsuan Li, Spencer C. H. Kuo, (unknown)	1
2	A Joint Model Based on Post-Treatment Longitudinal Prognostic Nutritional Index to Predict Survival in Nasopharyngeal Carcinoma 2024 ·Cancers ·(unknown), Yu‐Ming Wang, Shao‐Chun Wu, Wei‐Chih Chen, (unknown), Tai‐Jan Chiu, Yao‐Hsu Yang, Sheng‐Dean Luo	0
3	Intensity-modulated proton therapy versus volumetric-modulated ARC therapy in patients with nasopharyngeal carcinoma: A long-term, multicenter cohort study 2024 ·Radiotherapy and Oncology ·(unknown), Jung‐Der Wang, Wei‐Chih Chen, Chung‐Ying Lin, Tai‐Jan Chiu, Yao‐Hsu Yang, Joseph Tung‐Chieh Chang, Sheng‐Dean Luo, Yu‐Ming Wang	2
4	Real-World Data Validation of NAPOLI-1 Nomogram for the Prediction of Overall Survival in Metastatic Pancreatic Cancer 2023 ·Cancers ·Yung‐Yeh Su, Nai‐Jung Chiang, Yi‐Hsin Yang, Chia‐Jui Yen, Li‐Yuan Bai, Chang‐Fang Chiu, Shih‐Chang Chuang, Shih‐Hung Yang, Wen‐Chi Chou, Jen‐Shi Chen, Tai‐Jan Chiu, Yen‐Yang Chen, De-Chuan Chan, Cheng‐Ming Peng, (unknown), Chung‐Pin Li, Yan‐Shen Shan, Li‐Tzong Chen	5
5	Clinical Value of Endoscopic Esophageal Screening in Head and Neck Squamous Cell Carcinoma Patients 2023 ·Otolaryngology ·Wei‐Chih Chen, (unknown), Yu‐Ming Wang, Tai‐Jan Chiu, Shao‐Chun Wu, Yao‐Hsu Yang, Sheng‐Dean Luo	0
6	Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation 2023 ·Biomedical Journal ·Yung‐Yeh Su, Nai‐Jung Chiang, Tai‐Jan Chiu, (unknown), Shao‐Jung Hsu, (unknown), Shih‐Hung Yang, Youngsen Yang, Wen‐Chi Chou, Yen‐Yang Chen, Li‐Yuan Bai, Chung‐Pin Li, Jen‐Shi Chen	1
7	Combined Serum ALBUMIN with Neutrophil-to-Lymphocyte Ratio Predicts the Prognosis of Biliary Tract Cancer after Curative Resection 2023 ·Cancers ·Tai‐Jan Chiu, Yueh‐Wei Liu, Chee‐Chien Yong, (unknown), (unknown), Yen‐Yang Chen	3
8	Dosing Pattern and Early Cumulative Dose of Liposomal Irinotecan in Metastatic Pancreatic Cancer: A Real-World Multicenter Study 2022 ·Frontiers in Oncology ·Yung‐Yeh Su, Nai‐Jung Chiang, Chung‐Pin Li, Chia‐Jui Yen, Shih‐Hung Yang, Wen‐Chi Chou, Jen‐Shi Chen, Tai‐Jan Chiu, Yen‐Yang Chen, Shih‐Chang Chuang, Li‐Yuan Bai, Chang‐Fang Chiu, Cheng‐Ming Peng, De-Chuan Chan, (unknown), Yi‐Hsin Yang, Yan‐Shen Shan, Li‐Tzong Chen	6
9	Effect of glycated hemoglobin A1c on the survival of patients with oral squamous cell carcinoma: A multi-institutional database cohort study 2022 ·Frontiers in Oncology ·(unknown), Sheng‐Dean Luo, Wei‐Chih Chen, Shao‐Chun Wu, Tai‐Jan Chiu, Yu‐Ming Wang, Yao‐Hsu Yang, Fu‐Min Fang, Shau-Hsuan Li, Chung‐Yi Li, (unknown)	4
10	Development and Validation of a Novel Serum Prognostic Marker for Patients with Metastatic Colorectal Cancer on Regorafenib Treatment 2021 ·Cancers ·Yu‐Li Su, (unknown), Tai‐Jan Chiu, (unknown), Ko‐Chao Lee, Chien‐Chang Lu, Hong‐Hwa Chen, Chia‐Che Wu, Hung‐Chih Hsu	8
11	Low-dose aspirin confers a survival benefit in patients with pathological advanced-stage oral squamous cell carcinoma 2021 ·Scientific Reports ·Sheng‐Dean Luo, Shao‐Chun Wu, Wei‐Chih Chen, (unknown), Tai‐Jan Chiu, Yao‐Hsu Yang, Shau-Hsuan Li, Fu‐Min Fang, Tai‐Lin Huang, Chang‐Chun Hsiao, Chang‐Han Chen	5
12	Efficacy and safety of uracil-tegafur in patients with recurrent or metastatic thymic carcinoma 2020 ·Journal of Cancer Research and Practice ·Yen‐Yang Chen, (unknown), (unknown), (unknown), Yen‐Hao Chen, Tai‐Jan Chiu	1
13	Predictors of hospital expenses and hospital stay among patients undergoing total laryngectomy: Cost effectiveness analysis 2020 ·PLoS ONE ·Ming‐Hsien Tsai, Hui‐Ching Chuang, Yu‐Tsai Lin, (unknown), Fu‐Min Fang, Tai‐Lin Huang, Tai‐Jan Chiu, Shau-Hsuan Li, Chih‐Yen Chien	7
14	Safety and Efficacy of Immune Checkpoint Inhibitors for Patients With Metastatic Urothelial Carcinoma and End-Stage Renal Disease: Experiences From Real-World Practice 2020 ·Frontiers in Oncology ·Ming‐Chun Kuo, Po‐Jung Su, Chun‐Chieh Huang, Hao‐Lun Luo, Tai‐Jan Chiu, Shau-Hsuan Li, Chia‐Che Wu, Tingting Liu, Yuan‐Tso Cheng, Chih‐Hsiung Kang, Yu‐Li Su	12
15	Lenvatinib acts as the salvage therapy for advanced hepatocellular carcinoma 2018 ·Annals of Oncology ·(unknown), Yu‐Li Su, (unknown), (unknown), (unknown), Tai‐Jan Chiu, Sung‐Nan Pei, Chen‐Hsuan Wu, (unknown)	2
16	Betel nut chewing history is an independent prognosticator for smoking patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil 2016 ·World Journal of Surgical Oncology ·Yan-Ye Su, Chih‐Yen Chien, Sheng‐Dean Luo, (unknown), Wei-Che Lin, Fu‐Min Fang, Tai‐Jan Chiu, Yen‐Hao Chen, Chi‐Chih Lai, Cheng‐Ming Hsu, Shau-Hsuan Li	16
17	Intra-Arterial Chemotherapy with Doxorubicin and Cisplatin Is Effective for Advanced Hepatocellular Cell Carcinoma 2014 ·The Scientific World JOURNAL ·Ming‐Chun Ma, Yen‐Yang Chen, Shau-Hsuan Li, Yu‐Fan Cheng, Chih‐Chi Wang, Tai‐Jan Chiu, Sung‐Nan Pei, Chien-Ting Liu, Tai‐Lin Huang, (unknown), Yu‐Li Su, Yen‐Hao Chen, Sheng‐Nan Lu, Kun‐Ming Rau	14
18	Midkine neurite growth-promoting factor 2 expression as a potential prognostic marker of adjuvant therapy in head and neck squamous cell carcinoma 2013 ·Biomarkers ·Tai‐Jan Chiu, (unknown), Kun‐Ming Rau, Chang‐Han Chen, Chih‐Yen Chien, Shau-Hsuan Li, Hsin‐Ting Tsai, Hock‐Liew Eng	10
19	Neovascularization evaluated by CD105 correlates well with prognostic factors in breast cancers 2012 ·Experimental and Therapeutic Medicine ·Kun‐Ming Rau, Chao‐Cheng Huang, Tai‐Jan Chiu, Yen‐Yang Chen, Chien‐Chang Lu, Chien-Ting Liu, Sung‐Nan Pei, Yu‐Ching Wei	25
20	High ERCC1 expression predicts cisplatin-based chemotherapy resistance and poor outcome in unresectable squamous cell carcinoma of head and neck in a betel-chewing area 2011 ·Journal of Translational Medicine ·Tai‐Jan Chiu, Chang‐Han Chen, Chih‐Yen Chien, Shau-Hsuan Li, Hsin‐Ting Tsai, (unknown)	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact